Novel cancer vaccines with virus based cDNA libraries and monitoring for resistant tumour cell populations in prostate cancer

Project Information

ONCOVIRVAX

Grant agreement ID: 339167

Project closed

Start date 1 March 2014

End date 28 February 2019

Funded under

• Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 2 493 155,00

EU contribution € 2 493 155,00

Coordinated by

UNIVERSITY OF LEEDS
United Kingdom